Press Release

Exocrine Pancreatic Insufficiency Therapeutics Market Emerging Technologies, Key Players Analysis, Development Status, Opportunity Assessment Forecast to 2026

 The global exocrine pancreatic insufficiency therapeutics market to reach USD 2.55 billion by 2026, exhibiting a CAGR of 6.5% during the forecast period. Increasing prevalence of diabetes worldwide is touted to be one of the core factors fueling the growth of this market. According to the International Diabetes Federation (IDF), in 2019, approximately 463 million adults were suffering from diabetes and by 2045, this figure will rise to 700 million. In the same year, the disease caused deaths of 4.2 million people and around 374 million people are at an increased risk of developing type 2 diabetes. Diabetes cause microvascular damage which reduce pancreatic volume, inducing pancreatic fibrosis. According to the National Institutes of Health, those afflicted by type 1 diabetes have a 30 to 50% chance of developing exocrine pancreatic insufficiency, while those with type 2 have a 20 to 30% chance of developing the disorder. Thus, the exocrine pancreatic insufficiency therapeutics market stands to gain as a result.

Request a Sample Copy of Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/exocrine-pancreatic-insufficiency-market-100652

Key Industry Developments:

  • April 2016: Allergan plc received Positive Opinion by the Committee for Medicinal Products for Human Use for the commercial release of ENZEPI, the company’s flagship pancreatic enzyme replacement therapy (PERT) for patients with exocrine pancreatic insufficiency (EPI), in the European Union.
  • May 2018: VIVUS, Inc. announced its acquisition of product rights of Janssen Pharmaceuticals’ PANCREAZE, a pancreatic enzyme preparation consisting of pancrelipase, which is an extract derived from porcine pancreatic glands to treat EPI.

 

Key Industry Players:

  • AzurRx
  • AbbVie Inc.
  • CHIESI Farmaceutici S.p.A.
  • Allergan
  • Janssen Pharmaceuticals, Inc.

 

Table of Content from Exocrine Pancreatic Insufficiency Therapeutics Market:

  1. Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  4. Key Insights
    • Prevalence of Major Disorders Associated With Exocrine Pancreatic Insufficiency
    • Pipeline Analysis
    • Recent Industry Developments Such as Mergers, Partnerships & Acquisitions
    • Regulatory Scenario
    • New Product Launches
  5. Global Exocrine Pancreatic Insufficiency Therapeutics Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Therapy
      • Pancreatic Enzyme Replacement Therapy (PERT)
        • Creon
        • Zenpep
        • Others
      • Nutritional Therapy
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies & Drug Stores
      • Others
    • Market Analysis, Insights and Forecast – By Country
      • North America
      • Europe
      • Asia Pacific
      • Rest of the World
  1. North America Exocrine Pancreatic Insufficiency Therapeutics Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis – By Therapy
      • Pancreatic Enzyme Replacement Therapy (PERT)
        • Creon
        • Zenpep
        • Others
      • Nutritional Therapy
    • Market Analysis – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies & Drug Stores
      • Others
    • Market Analysis – By Country
      • S.
      • Canada

TOC Continued…..

More Trending Topics from Fortune Business Insights:

https://www.marketwatch.com/press-release/medical-devices-market-to-grow-at-53-cagr-to-reach-us-6021-bn-by-2025-2020-04-27?tesla=y

https://www.marketwatch.com/press-release/global-peritoneal-dialysis-market-is-expected-to-reach-us-60772-million-by-2025-2020-04-27?tesla=y

https://www.marketwatch.com/press-release/veterinary-therapeutics-market-to-reach-us-549683-mn-by-2025-on-account-of-rising-rd-activities-states-fortune-business-insights-2020-04-27?tesla=y

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close